CHEK2 Mutation with Heterozygote c.592+3A>T Variant in a Patient with Early Breast and Papillary Thyroid Cancer
Ozge Telci Caklili, Kubra Metli, Seda Erem Basmaz, Ayse Merve Ok Kurt, Ahmet Yesilyurt
(Endocrinol Res Pract 2025; 29: 283-284) DOI: 10.5152/erp.2025.25617